Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
Related news
RBI deputy governor Rajeshwar Rao highlights the shift in household savings from traditional bank deposits to mutual funds and capital markets, affecting banks' funding costs and margins. Rao warns against over-reliance on wholesale funding and urges banks to develop sophisticated stress-testing methodologies and maintain adequate liquidity buffers. He also emphasizes the need for NBFCs to diversify their funding sources.
Aditya Birla Group chairman Kumar Mangalam Birla identifies the “Trump factor†as influential in global dynamics for 2025. The US is a vital market for the conglomerate, which has invested over $15 billion there. Birla highlights India's emerging industrial strengths, exemplified by Apple's ecosystem shifting to India and UltraTech Cement's significant growth, reflecting India's role in global manufacturing.
Adani Total Gas Limited (ATGL) posted a net profit of Rs 142.38 crore for Q4 2024, marking a 19.4% decline YoY. However, revenues from operations increased by 12.5% YoY. Despite reduced APM gas allocation, ATGL ensured uninterrupted CNG supply and focused on expanding its network, adding new CNG stations and connections, including the new Jalandhar GA.
Global trade in 2025 is expected to transform due to geopolitical tensions, potential US-China trade wars, AI advancements, and sustainability demands. Experts urge Indian exporters to prioritize AI strategy and environmental standards to stay competitive. New technologies and trade agreements pushing sustainability are crucial for future trade dynamics.
Indian startups saw a funding revival in 2024, reaching $11.3 billion, slightly up from $10.7 billion in 2023. While VC firms have ample capital, they are cautiously deploying funds, prioritizing profitability and strong governance. Zepto led funding with $1.4 billion, but overall deal closures were uneven throughout the year. Investors remain optimistic about India's growth potential.
India's foreign exchange reserves have seen a significant decline of USD 8.714 billion, dropping to USD 625.871 billion for the week ended January 10. The reduction is attributed to revaluation and the Reserve Bank of India's efforts to stabilize rupee fluctuations, with foreign currency assets reducing by USD 9.469 billion.
Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio, including UNLOXCYT, an FDA-approved treatment for advanced skin cancer, expanding its global presence in oncology treatments.
India's technology sector workforce grew by 1.2 lakh in 2024-2025, fueled largely by Global Capability Centres (GCCs) hiring over 100,000 professionals. IT firms added only 11,000 employees, while GCCs continued to drive significant employment growth and further reinforce India's expanding tech industry.
Ankura Hospitals, a Hyderabad-based healthcare provider, has secured funding of Rs 165 crore from the Asian Development Bank to support its expansion plans. The strategic investment will enhance its facilities and healthcare services across India, particularly in pediatric, maternity, and gynecology care. Ankura currently operates over 1500 beds across 14 hospitals in multiple states.
India's aviation regulator, the DGCA, issued a show-cause notice to Akasa Air for alleged lapses in its operations manual and non-compliance with safety regulations. This follows a recent spot check revealing maintenance issues and pilot concerns about management practices and training standards.